14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 64 days ( 0 % )
Last Price $0.629 0 %
High/ Low $0.629 - $0.629 0%
Chg 7 Days N/A $0.629 $0.629
Chg 30 Days N/A $0.629 $0.629
Chg 12 mos -7.81 % $0.682 $0.629
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -11.47 % Width: 172.99 %
Pred. range - 3 mos $0.629 - $0.629 0 % - 0 %
Pred. range - 12 mos $0.270 - $0.738 -57.02 % - 17.32 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 28, 2023 - 69 days
Long MA avg 12 mos Sell Feb 10, 2023 - 80 days
Short/Long MA avg 12 mos Buy Jan 05, 2023 - 105 days
Pivot Short Sell Jun 05, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Sesen Bio Inc.

Sesen Bio Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscl... SESN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT